These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 32829962)

  • 1. The looming storm: Blood and cytokines in COVID-19.
    Kaur S; Bansal R; Kollimuttathuillam S; Gowda AM; Singh B; Mehta D; Maroules M
    Blood Rev; 2021 Mar; 46():100743. PubMed ID: 32829962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system.
    Lazzaroni MG; Piantoni S; Masneri S; Garrafa E; Martini G; Tincani A; Andreoli L; Franceschini F
    Blood Rev; 2021 Mar; 46():100745. PubMed ID: 32868115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic Complications of COVID-19 Infection: A Review.
    Castro RA; Frishman WH
    Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematologic disorders associated with COVID-19: a review.
    Rahi MS; Jindal V; Reyes SP; Gunasekaran K; Gupta R; Jaiyesimi I
    Ann Hematol; 2021 Feb; 100(2):309-320. PubMed ID: 33415422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
    Agbuduwe C; Basu S
    Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
    Xu K; Wei Y; Giunta S; Zhou M; Xia S
    Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
    Sasidharakurup H; Kumar G; Nair B; Diwakar S
    OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak.
    Griffin DO; Jensen A; Khan M; Chin J; Chin K; Saad J; Parnell R; Awwad C; Patel D
    J Glob Antimicrob Resist; 2021 Mar; 24():90-92. PubMed ID: 33242672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of COVID-19 Disease on Platelets and Coagulation.
    Wool GD; Miller JL
    Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and Sepsis.
    Koçak Tufan Z; Kayaaslan B; Mer M
    Turk J Med Sci; 2021 Dec; 51(SI-1):3301-3311. PubMed ID: 34590796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review.
    Lazaridis D; Leung S; Kohler L; Smith CH; Kearson ML; Eraikhuemen N
    J Pharm Pract; 2022 Dec; 35(6):1000-1006. PubMed ID: 33960219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities.
    Shama ; Mahmood A; Mehmood S; Zhang W
    Curr Issues Mol Biol; 2023 Aug; 45(9):7161-7182. PubMed ID: 37754237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.
    Savla SR; Prabhavalkar KS; Bhatt LK
    Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1397-1413. PubMed ID: 33832398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
    Hayıroğlu Mİ; Çınar T; Tekkeşin Aİ
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):842-848. PubMed ID: 32696883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
    Morrissey SM; Geller AE; Hu X; Tieri D; Ding C; Klaes CK; Cooke EA; Woeste MR; Martin ZC; Chen O; Bush SE; Zhang HG; Cavallazzi R; Clifford SP; Chen J; Ghare S; Barve SS; Cai L; Kong M; Rouchka EC; McLeish KR; Uriarte SM; Watson CT; Huang J; Yan J
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33986193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.